181 related articles for article (PubMed ID: 34207414)
1. Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers.
Thagaard J; Stovgaard ES; Vognsen LG; Hauberg S; Dahl A; Ebstrup T; Doré J; Vincentz RE; Jepsen RK; Roslind A; Kümler I; Nielsen D; Balslev E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207414
[TBL] [Abstract][Full Text] [Related]
2. Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.
Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Santos J; García P; Massó J; Bellosillo B; Lloveras B; Albanell J; Vázquez I; Comerma L
Virchows Arch; 2023 Nov; 483(5):655-663. PubMed ID: 37500796
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.
Geurts VCM; Balduzzi S; Steenbruggen TG; Linn SC; Siesling S; Badve SS; DeMichele A; Ignatiadis M; Leon-Ferre RA; Goetz MP; Wolff AC; Klar N; Michiels S; Loi S; Adams S; Horlings HM; Sonke GS; Salgado R; Kok M
JAMA Oncol; 2024 Jun; ():. PubMed ID: 38935352
[TBL] [Abstract][Full Text] [Related]
4. Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Thagaard J; Broeckx G; Page DB; Jahangir CA; Verbandt S; Kos Z; Gupta R; Khiroya R; Abduljabbar K; Acosta Haab G; Acs B; Akturk G; Almeida JS; Alvarado-Cabrero I; Amgad M; Azmoudeh-Ardalan F; Badve S; Baharun NB; Balslev E; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Bouchmaa N; Burgues O; Chardas A; Chon U Cheang M; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dahl AB; Dantas Portela FL; Deman F; Demaria S; Doré Hansen J; Dudgeon SN; Ebstrup T; Elghazawy M; Fernandez-Martín C; Fox SB; Gallagher WM; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hart SN; Hartman J; Hauberg S; Hewitt S; Hida AI; Horlings HM; Husain Z; Hytopoulos E; Irshad S; Janssen EA; Kahila M; Kataoka TR; Kawaguchi K; Kharidehal D; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Ly A; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rahman A; Rajpoot NM; Rapoport BL; Rau TT; Reis-Filho JS; Ribeiro JM; Rimm D; Roslind A; Vincent-Salomon A; Salto-Tellez M; Saltz J; Sayed S; Scott E; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Fineberg S; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; van Diest PJ; Verghese GE; Viale G; Vieth M; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Zin RM; Adams S; Bartlett J; Loibl S; Denkert C; Savas P; Loi S; Salgado R; Specht Stovgaard E
J Pathol; 2023 Aug; 260(5):498-513. PubMed ID: 37608772
[TBL] [Abstract][Full Text] [Related]
5. Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes.
Ni Y; Tsang JY; Shao Y; Poon IK; Tam F; Shea KH; Tse GM
Oncologist; 2022 Apr; 27(4):e313-e327. PubMed ID: 35380716
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
[TBL] [Abstract][Full Text] [Related]
7. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
[TBL] [Abstract][Full Text] [Related]
8. Joint Region and Nucleus Segmentation for Characterization of Tumor Infiltrating Lymphocytes in Breast Cancer.
Amgad M; Sarkar A; Srinivas C; Redman R; Ratra S; Bechert CJ; Calhoun BC; Mrazeck K; Kurkure U; Cooper LA; Barnes M
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10956():. PubMed ID: 31997849
[TBL] [Abstract][Full Text] [Related]
9. An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.
Bai Y; Cole K; Martinez-Morilla S; Ahmed FS; Zugazagoitia J; Staaf J; Bosch A; Ehinger A; Nimeus E; Hartman J; Acs B; Rimm DL
Clin Cancer Res; 2021 Oct; 27(20):5557-5565. PubMed ID: 34088723
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Adams S; Gray RJ; Demaria S; Goldstein L; Perez EA; Shulman LN; Martino S; Wang M; Jones VE; Saphner TJ; Wolff AC; Wood WC; Davidson NE; Sledge GW; Sparano JA; Badve SS
J Clin Oncol; 2014 Sep; 32(27):2959-66. PubMed ID: 25071121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
Gao G; Wang Z; Qu X; Zhang Z
BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
[TBL] [Abstract][Full Text] [Related]
12. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Kolberg-Liedtke C; Feuerhake F; Garke M; Christgen M; Kates R; Grischke EM; Forstbauer H; Braun M; Warm M; Hackmann J; Uleer C; Aktas B; Schumacher C; Kuemmel S; Wuerstlein R; Graeser M; Nitz U; Kreipe H; Gluz O; Harbeck N
Breast Cancer Res; 2022 Sep; 24(1):58. PubMed ID: 36056374
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer.
Albusayli R; Graham JD; Pathmanathan N; Shaban M; Raza SEA; Minhas F; Armes JE; Rajpoot N
J Pathol; 2023 May; 260(1):32-42. PubMed ID: 36705810
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer.
AiErken N; Shao N; Liu Y; Shi H; Shi Y; Yuan Z; Lin Y
Breast Care (Basel); 2023 Oct; 18(5):390-398. PubMed ID: 37901045
[TBL] [Abstract][Full Text] [Related]
15. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
Loi S; Michiels S; Adams S; Loibl S; Budczies J; Denkert C; Salgado R
Ann Oncol; 2021 Oct; 32(10):1236-1244. PubMed ID: 34311075
[TBL] [Abstract][Full Text] [Related]
16. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
[TBL] [Abstract][Full Text] [Related]
17. A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer.
Sun P; He J; Chao X; Chen K; Xu Y; Huang Q; Yun J; Li M; Luo R; Kuang J; Wang H; Li H; Hui H; Xu S
EBioMedicine; 2021 Aug; 70():103492. PubMed ID: 34280779
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
[TBL] [Abstract][Full Text] [Related]
19. Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and
Telli ML; Chu C; Badve SS; Vinayak S; Silver DP; Isakoff SJ; Kaklamani V; Gradishar W; Stearns V; Connolly RM; Ford JM; Gruber JJ; Adams S; Garber J; Tung N; Neff C; Bernhisel R; Timms KM; Richardson AL
Clin Cancer Res; 2020 Jun; 26(11):2704-2710. PubMed ID: 31796517
[TBL] [Abstract][Full Text] [Related]
20. Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.
Choi S; Cho SI; Jung W; Lee T; Choi SJ; Song S; Park G; Park S; Ma M; Pereira S; Yoo D; Shin S; Ock CY; Kim S
NPJ Breast Cancer; 2023 Aug; 9(1):71. PubMed ID: 37648694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
